Continue to site >
Trending ETFs

Name

As of 06/02/2026

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$187.22

$36.8 B

0.07%

$0.14

0.33%

Vitals

YTD Return

-4.7%

1 yr return

16.1%

3 Yr Avg Return

4.0%

5 Yr Avg Return

4.6%

Net Assets

$36.8 B

Holdings in Top 10

40.8%

52 WEEK LOW AND HIGH

$190.2
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 0.33%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 15.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$3,000

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 06/02/2026

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$187.22

$36.8 B

0.07%

$0.14

0.33%

VGHCX - Profile

Distributions

  • YTD Total Return -4.7%
  • 3 Yr Annualized Total Return 4.0%
  • 5 Yr Annualized Total Return 4.6%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio 0.82%
DIVIDENDS
  • Dividend Yield 0.1%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Vanguard Health Care Fund
  • Fund Family Name
    Vanguard
  • Inception Date
    Jan 03, 1994
  • Shares Outstanding
    N/A
  • Share Class
    Investor
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Jean Hynes

Fund Description

The Fund employs an active management approach. Under normal circumstances, the Fund invests at least 80% of its net assets,plus the amount of any borrowings for investment purposes, in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. For purposes of the 80% policy, these companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities,and the Fund may also consider companies engaged in medical, diagnostic, biochemical, and other research and development activities. The Fund’s advisor strives for a balanced representation of the health care field, searching for the best values in the various subsectors of the industry. The Fund may invest up to 50% of its assets in foreign stocks.The Fund is considered nondiversified, as defined under the Investment Company Act of 1940, which means that it may invest a greater percentage of its assets in the securities of particular issuers as compared with diversified mutual funds.As a matter of fundamental policy, the Fund concentrates its investments (i.e., invests more than 25% of its assets) in the securities of issuers whose principal business activities are in the health care industry.
Read More

VGHCX - Performance

Return Ranking - Trailing

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
YTD -4.7% -22.9% 20.0% 85.63%
1 Yr 16.1% -20.4% 134.5% 60.00%
3 Yr 4.0%* -6.3% 23.9% 87.50%
5 Yr 4.6%* -15.5% 12.3% 37.42%
10 Yr 7.5%* 3.0% 13.1% 67.72%

* Annualized

Return Ranking - Calendar

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
2025 12.2% -21.9% 61.0% 50.63%
2024 -12.8% -28.2% 19.2% 95.00%
2023 -1.9% -8.6% 19.0% 76.25%
2022 -6.3% -53.9% 3.2% 15.48%
2021 5.4% -39.6% 24.2% 30.97%

Total Return Ranking - Trailing

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
YTD -4.7% -22.9% 20.0% 85.63%
1 Yr 16.1% -20.4% 134.5% 60.00%
3 Yr 4.0%* -6.3% 23.9% 87.50%
5 Yr 4.6%* -15.5% 12.3% 37.42%
10 Yr 7.5%* 3.0% 13.1% 67.72%

* Annualized

Total Return Ranking - Calendar

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
2025 17.3% -0.5% 63.7% 49.38%
2024 -1.6% -28.2% 19.2% 90.00%
2023 5.4% -8.6% 19.0% 40.00%
2022 -1.1% -53.9% 3.7% 8.39%
2021 14.3% -33.9% 26.0% 29.68%

NAV & Total Return History


VGHCX - Holdings

Concentration Analysis

VGHCX Category Low Category High VGHCX % Rank
Net Assets 36.8 B 6.38 M 37.9 B 1.25%
Number of Holdings 101 24 416 35.63%
Net Assets in Top 10 16 B 3.49 M 22.8 B 1.25%
Weighting of Top 10 40.79% 16.2% 79.4% 66.25%

Top 10 Holdings

  1. ELI LILLY CO 9.76%
  2. ASTRAZENECA PLC 5.49%
  3. MERCK CO 5.09%
  4. UNITEDHEALTH GRP 3.49%
  5. JOHNSONJOHNSON 3.11%
  6. EDWARDS LIFE 3.10%
  7. GSK PLC 2.98%
  8. DANAHER CORP 2.70%
  9. ABBOTT LABS 2.58%
  10. INTUITIVE SURGIC 2.50%

Asset Allocation

Weighting Return Low Return High VGHCX % Rank
Stocks
97.63% 88.27% 106.13% 58.13%
Other
2.05% -22.99% 4.13% 6.88%
Cash
0.32% 0.00% 32.31% 85.63%
Preferred Stocks
0.00% 0.00% 7.86% 69.38%
Convertible Bonds
0.00% 0.00% 0.37% 52.26%
Bonds
0.00% 0.00% 12.39% 59.38%

Stock Sector Breakdown

Weighting Return Low Return High VGHCX % Rank
Healthcare
100.00% 59.26% 100.00% 25.16%
Utilities
0.00% 0.00% 0.00% 48.39%
Technology
0.00% 0.00% 22.69% 51.61%
Real Estate
0.00% 0.00% 5.89% 51.61%
Industrials
0.00% 0.00% 7.02% 51.61%
Financial Services
0.00% 0.00% 1.60% 64.52%
Energy
0.00% 0.00% 0.00% 48.39%
Communication Services
0.00% 0.00% 9.11% 50.97%
Consumer Defense
0.00% 0.00% 25.73% 54.84%
Consumer Cyclical
0.00% 0.00% 1.92% 50.32%
Basic Materials
0.00% 0.00% 7.16% 67.74%

Stock Geographic Breakdown

Weighting Return Low Return High VGHCX % Rank
US
72.51% 60.50% 104.41% 95.00%
Non US
25.11% 0.00% 36.86% 6.25%

VGHCX - Expenses

Operational Fees

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.33% 0.08% 4.69% 96.25%
Management Fee 0.32% 0.03% 1.25% 4.38%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 15.00% 1.00% 238.00% 8.70%

VGHCX - Distributions

Dividend Yield Analysis

VGHCX Category Low Category High VGHCX % Rank
Dividend Yield 0.07% 0.00% 6.24% 9.38%

Dividend Distribution Analysis

VGHCX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual Annual Annual

Net Income Ratio Analysis

VGHCX Category Low Category High VGHCX % Rank
Net Income Ratio 0.82% -2.54% 1.85% 8.50%

Capital Gain Distribution Analysis

VGHCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Semi-Annually Annually

Distributions History

View More +

VGHCX - Fund Manager Analysis

Managers

Jean Hynes


Start Date

Tenure

Tenure Rank

May 29, 2008

14.01

14.0%

Jean M. Hynes, CFA Chief Executive Officer, Managing Partner, and Portfolio Manager As the chief executive officer of Wellington Management Company LLP, Jean leads the firm in our mission to drive excellence for clients to positively impact millions of beneficiaries’ lives. In pursuit of that mission, she spends significant time meeting with clients globally as well as working to strengthen and support the firm’s people and capabilities. She also serves on a variety of internal management committees, including the executive, operating, and compensation committees. In addition, she is one o

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 8.08 0.25